Background: Alcoholic hepatitis (AH) is one of the most severe forms of alcoholic liver disease. Recently, a histologic scoring system for predicting prognosis in this patient cohort was proposed as Alcoholic Hepatitis Histologic Score (AHHS). We aimed to assess interobserver variability in recognizing histologic features of AH and the effect of this variability on the proposed AHHS categories.
A LCOHOLIC LIVER DISEASE is likely to be the most common form of liver disease (Guirguis et al., 2015) . Alcoholic hepatitis (AH) is one of the most severe forms of alcohol-induced liver injury and is clinically characterized by jaundice and liver failure, with a high short-term mortality (Dominguez et al., 2008) . The high short-term mortality calls for more accurate patient characterization and modern targeted therapies in AH. Recent AASLD guidelines recommended a liver biopsy should be considered for patients with a clinical diagnosis of severe AH and for patients in whom reasonable uncertainty exists regarding the presence of underlying liver disease (O'Shea et al., 2010) . Recently, a histologic scoring system, the Alcoholic Hepatitis Histologic Score (AHHS), was proposed as an objective histologic measure to determine the prognosis of patients with AH. The AHHS is based on several histologic features including bridging fibrosis or cirrhosis, canalicular and/or ductular bilirubinostasis or canalicular and/or ductular plus hepatocellular bilirubinostasis, megamitochondria, and severe neutrophil (polymorphonuclear leukocyte [PMN] ) infiltration. The final score is simplified into 3 categories: mild, 0 to 3 points; moderate, 4 to 5 points; severe 6 to 9 points. AHHS is associated with the severity of AH and predicts risk of death within 90 days in patients with AH (Altamirano et al., 2014) . Although expert liver pathologists performed histologic assessment of liver specimens, and 71 slide kits were cross-shared for histologic interpretation between the central pathologist and the other participant centers, the interobserver agreement was not reported. Furthermore, evaluation of liver biopsies by expert liver pathologists participating in a well-designed study is not part of routine clinical practice. Therefore, the aim of this study was to examine the interobserver agreement on the histologic features of AH using a cohort of clinically and histologically proven AH cases retrieved from 1 institute and to examine the feasibility of AHHS in routine clinical setting.
MATERIALS AND METHODS
After Institutional Review Board approval, patients who were diagnosed with AH or alcoholic cirrhosis identified by screening of the electronic medical records at the Cleveland Clinic between January 1, 2000, and February 28, 2015 , were included in this study. Of the 801 patients identified on the screening evaluation, 739 (92.3%) had a liver biopsy. Patients were only included if the time difference between the biopsy and the laboratory results was less than a month. This resulted in a cohort of 51 cases of the previously screened 739 patients. From these 51 patients, 32 patients had hematoxylin-eosin (H&E)-and trichrome-stained slides available for review.
H&E-and trichrome-stained slides of the included patients were de-identified and independently reviewed by 5 pathologists masked to the clinical findings and outcome. All pathologists had gastrointestinal (GI) and liver pathology fellowship training followed by 4 to 8 years of practice post-GI and liver pathology fellowship. Of the 5 pathologists, 3 routinely review liver biopsy daily (classified as liver pathologists in this study) with an average of about 10 liver biopsies per day and the other 2 review primarily luminal GI pathology (classified as GI pathologists in this study). A variety of histologic features were assessed according to the methods and criteria described previously (Altamirano et al., 2014; Kleiner et al., 2005) ( Table 1) . The AHHS was then generated using the fibrosis stage, presence or absence of bilirubinostasis, PMN infiltration, and megamitochondria, and an AHHS category (mild, moderate, severe) was assigned (Table 2) (Altamirano et al., 2014) .
Fleiss' kappa was used to assess the interobserver agreement on each histologic feature and AHHS. A j value < 0, 0.01 to 0.20, 0.21 to 0.40, 0.41 to 0.60, 0.61 to 0.80, 0.81 to 1.0 is considered poor, slight, fair, moderate, substantial, and almost perfect agreement, respectively (Landis and Koch, 1977) . A p-value < 0.05 was considered statistically significant. Statistical analysis was performed using R 2.15.2 (R Development Core Team, Vienna, Austria).
RESULTS
The consensus histologic data are shown in Table 3 . A consensus for each feature is defined as an interpretation agreed upon by at least 3 of the 5 pathologists. In this cohort of patients, 75% of biopsies had bridging fibrosis or cirrhosis, 21% had marked ballooning, 19% had marked Mallory hyalines, 31% had marked neutrophilic inflammation, 23% had bilirubinostasis, and 18% had megamitochondria. Moderate or severe steatosis was seen only in 25% of cases. Approximately 13, 31, and 56% biopsies were categorized to the mild, moderate, and severe AHHS, respectively.
A slight-to-moderate level of interobserver agreement was reached among the 5 reviewers on the histopathologic features of AH with j values ranging from 0.20 (95% CI: 0.03 to 0.46, megamitochondria) to 0.52 (95% CI: 0.40 to 0.68, PMN infiltration) (Table 4) . Consequently, there was overall only a fair level of agreement in assigning the different AHHS categories to a case (j value = 0.33, 95% CI: 0.20 to 0.51). No mononuclear inflammation 0 A few mononuclear inflammation in the sinusoids, portal tracts, or in the lobules 1 Dense mononuclear inflammation in the portal tracts and/or lobules 2
As only 3 of the 5 pathologists were regularly reviewing liver biopsies daily, Fleiss's kappa was used to assess the interobserver agreement among these 3 liver pathologists and the 2 GI pathologists separately on each of the histologic features and the aggregate AHHS. The results are shown in Table 5 . Liver pathologists were noted to have better interobserver agreement on certain histologic features such as lobular fibrosis (j value 0.27 vs. 0.13), pericellular fibrosis (j value 0.48 vs. 0.00), bilirubinostasis (j value 0.54 vs. 0.37), Mallory hyalines (j value 0.50 vs. 0.22), and megamitochondria (j value 0.40 vs. -0.26). The assessment of overall fibrosis and PMN infiltration was comparable between liver and GI pathologists (j value 0.41 vs. 0.38 for overall fibrosis and 0.48 vs. 0.40 PMN infiltrates). On the other hand, GI pathologists had a slightly better agreement on steatosis (j value 0.42 vs. 0.34) and hepatocyte ballooning (j value 0.40 vs. 0.24). Importantly, 2 of the 4 features used for AHHS, bilirubinostasis, and megamitochondria were more consistently diagnosed by liver pathologists, and the other 2 features (overall fibrosis and PMN inflammation) were recognized by liver and GI pathologists with comparable interobserver agreement. Common features of AH are illustrated in Fig. 1 .
Eighteen of 32 (56%) biopsies were uniformly assigned to an AHHS category by all 3 liver pathologists (j value of 0.40, 95% CI: 0.22 to 0.60) with the following distribution: 11 severe, 6 moderate, and 1 mild. Of the remaining biopsies, 11 of 32 (34%) cases were assigned by 2 liver pathologists to the same AHHS category including 3 severe, 3 moderate, and 5 mild. The remainder (3 of 32, 10%) were assigned to different categories by all 3 liver pathologists. Overall, AHHS categories were more consistently assigned (j value = 0.40, 95% CI: 0.20 to 0.51) by liver pathologists when compared to GI pathologists (j value 0.06, 90% CI: À0.20 to 0.33).
DISCUSSION
AH, the most severe form of alcoholic liver disease, carries a short-term mortality as high as 20 to 30% (Dominguez et al., 2008) . Although AH has a constellation of histologic features that supports the diagnosis, a biopsy scoring system of prognostic significance was only published recently (Altamirano et al., 2014) in a multicentric study. The AHHS gives 3 points for the presence of bridging fibrosis or cirrhosis, 1 point for canalicular or ductular bilirubinostasis or 2 points for canalicular or ductular bilirubinostasis plus hepatocellular bilirubinostasis, 2 points for a lack of or only mild neutrophilic inflammation, and 2 points for a lack of megamitochondria. The AHHS is further divided into mild (0 to 3 points), moderate (4 to 5 points), and severe (6 to 9 points) which predicts a low (3%), moderate (19%), and high (51%) risk of death within 90 days (Altamirano et al., 2014) . However, whether pathologists in a routine clinical setting can reliably recognize these features has not been investigated.
Biopsy interpretation for the diagnosis of alcoholic liver disease requires the recognition of many individual features. High interobserver variability in recognizing these histologic features has been previously reported by others (Bedossa et al., 1988; Kleiner et al., 2005) . The presence of major and minor discrepancies in a "second opinion" on liver biopsy interpretation has also been previously reported (Bejarano et al., 2001; Colling et al., 2014; Paterson et al., 2016) . In 1 study of nonalcoholic fatty liver disease involving a panel of liver pathologists, a j value of 0.15 to 0.84 was reported for a variety of histologic features (Kleiner et al., 2005) . Not surprisingly, the lowest j value was reported for megamitochondria (in adult cases 0.15 and À0.03 for pediatric cases) and the highest j value for fibrosis (j 0.84) and steatosis (j 0.79). This finding reaffirms the high interobserver variability in identifying megamitochondria, a feature not commonly or actively searched for diagnostic purposes in routine liver biopsy interpretation. Bedossa and colleagues (1988) examined interobserver variation in the assessment of liver biopsies of alcoholic patients and reported a moderate concordance for steatosis (j value of 0.47) but a lower concordance for fibrosis alone (j value of 0.16) between 2 pathologists. In our study, multiple histologic features were assessed by 5 pathologists, with 3 of them having specific expertise as hepatopathologists. The steatosis grade, fibrosis stage, PMN inflammation, bilirubinostasis, and Mallory hyaline had moderate agreement with j value of 0.43, 0.42, 0.52, 0.5, and 0.44, respectively. The interobserver agreement for steatosis was similar to previously reported in liver biopsies from alcoholic patients (Bedossa et al., 1988) but lower than that for nonalcoholic fatty liver disease (Kleiner et al., 2005) . This may reflect a true difficulty in steatosis assessment in alcoholic liver disease due to more prominent ballooning, pericellular fibrosis, and in some cases foamy degeneration. The overall fibrosis staging assessment in our study had a moderate agreement that was better than that previously reported in liver biopsies from alcoholic patients (Bedossa et al., 1988) but worse than that reported for nonalcoholic fatty liver disease (j of 0.85; Kleiner et al., 2005) . This may be related to the more frequently fragmented biopsies in patients with more advanced lobular fibrosis that may interfere with fibrosis interpretation. As 3 of the 5 reviewers review liver biopsies as a major part of their reporting, a further analysis was performed to investigate the j value among these 3 liver pathologists. Indeed, the j value for all examined histologic features was higher except for steatosis and ballooning. For features included in AHHS, the j value was higher among liver pathologists (0.41 vs. 0.38 for fibrosis, 0.54 vs. 0.37 for bilirubinostasis, 0.40 vs. À0.26 for megamitochondria, and 0.48 vs. 0.40 for PMN inflammation between liver and nonliver pathologists, respectively). These data suggest a greater interobserver agreement in AHHS categories assignment among liver pathologists that practice in a high-volume liver biopsy setting. Furthermore, uniform agreement could not be reached in a significant proportion of the cases (44%) raising some concerns regarding the general application of AHHS as a predictor of prognosis in AH.
Major strengths of this study are that it is one of the largest cohorts of patients with AH from a single institute and the diagnosis was confirmed by clinical and histologic criteria. In addition, all liver biopsies were obtained within 1 month of the laboratory results. Furthermore, all the reviewing pathologists had undergone training in GI and liver pathology fellowship. In contrast to previous reports with higher interobserver agreement, our study included a large number of pathologists with differences in years of experience, training at different institutions, and current practices, which is more representative of pathologists nationwide. A limitation of the present study is that the review results including the AHHS were not correlated with clinical findings, laboratory test results, or the patients' outcome. However, the goal of the study was not to determine the prognostic value that has been previously reported, but rather to determine the variability in the interpretation of histologic characteristics that constitute components of the AHHS. All liver biopsies were taken within 1 month of laboratory results, but the exact time interval between liver biopsy from onset of disease or time of admission was not clear. The AH population in this study may be different from the study population in previous studies as our study patients had lower frequency of marked ballooning, many Mallory hyalines, megamitochondria, and bilirubinostasis. This may be related to the large number of cases with advanced fibrosis in our cohort. Only 3 liver pathologists and 2 GI pathologists participated in this study, so the feature recognition difference between these 2 small groups may not be representative. Finally, all the pathologists had specialized GI/liver fellowship training and pathologists without GI/liver fellowship training were not included. However, this is also a strength of the study because based on the variability among pathologists with specialized training, one would expect an even greater variability between nonspecialized pathologists, suggesting that such biopsies should preferably be reviewed by pathologists with advanced training and continued interest in liver pathology.
In summary, our study for the first time examined the interobserver variability on several previously reported histologic features of AH that predict outcome in a clinical practice outside of a research setting. An AHHS could only be assigned with a fair level of agreement (j value of 0.33) in our study and only 18 of 32 (56%) were uniformly assigned to an AHHS category by 3 liver pathologists. Our data are consistent with previous literature and reaffirms the high interobserver variability in liver biopsy interpretation. Additionally, our data identify megamitochondria as one of the most difficult features to recognize in AH. Even though pathologists practicing in a high-volume liver biopsy setting may have a better interobserver agreement, clinicians applying the AHHS as a predictor of prognosis in AH should consider this with caution, based on the limitations identified in our study. Whether training sessions will harmonize the interpretation of individual parameters among pathologists and improve interobserver agreement in scoring liver biopsies with a diagnosis of AH remains to be determined by future studies. 
